Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1

NCT03830229 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT03830229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03830229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Recruiting
Start date
March 13, 2019
Completion date
December 31, 2034
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

families, mesothelioma